OPNT
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
OPNT
Delisted
OPNT was delisted on the 1st of March, 2023.
28 hedge funds and large institutions have $13.2M invested in Opiant Pharmaceuticals, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
1% less capital invested
Capital invested by funds: $13.3M → $13.2M (-$122K)
Holders
28
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$376K | |
| 2 | +$294K | |
| 3 | +$89.5K | |
| 4 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$87.5K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$53.1K |
Top Sellers
| 1 | -$295K | |
| 2 | -$36.4K | |
| 3 | -$21.2K | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$10K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$9.87K |